DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,760.00
-80.00 (-1.37%)
At close: Dec 5, 2025

DongKoo Bio & Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
155,763131,049156,349169,609232,556240,580
Upgrade
Market Cap Growth
8.46%-16.18%-7.82%-27.07%-3.33%-
Upgrade
Enterprise Value
240,268172,921172,036175,056221,869244,593
Upgrade
Last Close Price
5760.004800.005520.255861.217711.267735.30
Upgrade
PE Ratio
206.9564.3813.2425.6424.9426.32
Upgrade
PS Ratio
0.650.530.730.871.501.73
Upgrade
PB Ratio
1.411.241.421.662.322.54
Upgrade
P/TBV Ratio
1.481.421.571.822.402.60
Upgrade
P/FCF Ratio
---14.3217.05108.33
Upgrade
P/OCF Ratio
-7.5643.6110.0812.9932.13
Upgrade
EV/Sales Ratio
1.010.690.800.901.431.76
Upgrade
EV/EBITDA Ratio
16.198.668.337.7916.8220.19
Upgrade
EV/EBIT Ratio
40.2413.6311.7710.4027.2632.14
Upgrade
EV/FCF Ratio
-12.93--14.7816.27110.14
Upgrade
Debt / Equity Ratio
0.970.820.400.340.240.25
Upgrade
Debt / EBITDA Ratio
7.214.342.121.531.841.96
Upgrade
Debt / FCF Ratio
---2.901.7810.69
Upgrade
Asset Turnover
0.941.151.191.191.04-
Upgrade
Inventory Turnover
1.982.202.262.742.52-
Upgrade
Quick Ratio
0.410.500.610.830.971.17
Upgrade
Current Ratio
0.930.931.211.321.481.79
Upgrade
Return on Equity (ROE)
0.63%1.84%11.11%6.54%9.58%-
Upgrade
Return on Assets (ROA)
1.47%3.65%5.03%6.44%3.40%-
Upgrade
Return on Capital (ROIC)
1.83%4.58%6.29%8.07%4.19%-
Upgrade
Return on Capital Employed (ROCE)
4.00%9.90%12.40%15.90%7.80%7.30%
Upgrade
Earnings Yield
0.49%1.55%7.56%3.90%4.01%3.80%
Upgrade
FCF Yield
-11.93%-3.45%-6.56%6.98%5.86%0.92%
Upgrade
Payout Ratio
421.26%162.74%25.72%42.39%10.11%10.32%
Upgrade
Buyback Yield / Dilution
-0.89%1.13%0.48%1.78%0.12%-25.96%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.